Anastrozole and Osteoporosis: The Bone Loss Risk in Breast Cancer Care
Anastrozole lowers estrogen production and therefore accelerates bone loss, making osteoporosis a real and measurable risk for postmenopausal women who take it after breast cancer.
Read the story ↗

